#Bristol Myers Squibb
articles
Health
FDA Approves First CELMoD Drug Iberdomide for Relapsed Multiple Myeloma
Bristol Myers Squibb's oral iberdomide, paired with daratumumab and dexamethasone, becomes the first CELMoD approved for...
Markets
IC Podcast: $400bn Pharma Rumour, AI Jobs Fears, and Smith & Nephew’s Stalled Turnaround
Investors’ Chronicle weighs a rumoured AstraZeneca–Bristol Myers megamerger, probes whether AI will really destroy jobs,...
Companies
AstraZeneca and Bristol Myers in Talks Over Potential $400 Billion Pharma Merger
Report says the two drugmakers discussed a merger that would create a $400 billion oncology powerhouse, but the talks co...
Companies
AstraZeneca–BMS Merger Report Sends Shares Tumbling Into Antitrust Spotlight
Investors sold AstraZeneca after a report it held preliminary merger talks with Bristol Myers Squibb, while analysts que...
Companies
AstraZeneca and Bristol Myers Squibb in Talks Over $400bn Pharma Merger
AstraZeneca and Bristol Myers Squibb are in merger talks that could create a nearly $400bn pharmaceutical giant, the Fin...
Markets
FTSE Held Back as AstraZeneca Slumps on $400bn Bristol Myers Talks
AstraZeneca's 6% slide and cheaper oil keep the FTSE behind Europe, as traders turn to US jobs reports ahead of the Fed'...